MeSH term
Frequency | Condition_Probility | Adult | 11 | 0.0 |
Female | 17 | 0.0 |
Humans | 60 | 0.0 |
Male | 15 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Animals | 24 | 0.0 |
Chromatin/*metabolism | 4 | 3.0 |
Cytosol/metabolism | 2 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Mitosis | 2 | 0.0 |
Peptide Mapping | 2 | 0.0 |
Phosphorylation | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 41 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Lamin Type B | 11 | 84.0 |
Lamins | 13 | 24.0 |
Protein Structure, Tertiary | 4 | 0.0 |
COS Cells | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Endoplasmic Reticulum/metabolism | 3 | 1.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Nuclear Envelope/metabolism | 6 | 18.0 |
Receptors, Cytoplasmic and Nuclear/*metabolism | 6 | 4.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Solubility | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
Tretinoin/*pharmacology | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Case-Control Studies | 4 | 0.0 |
DNA Primers/genetics | 2 | 0.0 |
Genotype | 2 | 0.0 |
Nuclear Proteins/*genetics | 3 | 0.0 |
Follicle Stimulating Hormone/blood | 2 | 0.0 |
Pregnancy Outcome | 3 | 1.0 |
Retrospective Studies | 6 | 0.0 |
Time Factors | 2 | 0.0 |
Pregnancy | 6 | 0.0 |
Aged | 4 | 0.0 |
Middle Aged | 3 | 0.0 |
Embryo Implantation | 2 | 5.0 |
*Fertilization in Vitro | 2 | 1.0 |
*Pregnancy Outcome | 2 | 3.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Nuclear Proteins/*metabolism | 2 | 0.0 |
Phenotype | 2 | 0.0 |
Amino Acid Sequence | 14 | 0.0 |
DNA-Binding Proteins/*metabolism | 2 | 0.0 |
Nuclear Envelope/*metabolism | 6 | 22.0 |
Protein Binding | 5 | 0.0 |
3T3 Cells | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Kinetics | 3 | 0.0 |
Mice | 5 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Nuclear Proteins/metabolism | 3 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Recombinant Fusion Proteins/chemistry/metabolism | 3 | 1.0 |
Sequence Homology, Amino Acid | 9 | 0.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
Lamin Type A | 3 | 13.0 |
Oxidoreductases/*genetics | 2 | 2.0 |
Antibody Specificity | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
English Abstract | 4 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Rabbits | 3 | 0.0 |
Rats | 4 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*genetics/metabolism | 3 | 10.0 |
Immunoblotting | 4 | 0.0 |
Hela Cells | 5 | 0.0 |
Transfection | 2 | 0.0 |
Binding Sites | 3 | 0.0 |
Mitochondria, Liver/immunology | 2 | 25.0 |
Nuclear Envelope/*immunology | 2 | 66.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Mutation | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*chemistry/metabolism | 2 | 16.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Xenopus | 2 | 0.0 |
*Point Mutation | 2 | 0.0 |
Receptors, Cytoplasmic and Nuclear/*genetics | 4 | 5.0 |
Liver Cirrhosis, Biliary/*immunology | 2 | 5.0 |
Nuclear Proteins/*immunology | 2 | 9.0 |
Birth Rate | 2 | 25.0 |
Pregnancy Rate | 3 | 2.0 |
*Sperm Injections, Intracytoplasmic | 2 | 12.0 |
Chickens | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Autoantibodies/blood | 2 | 1.0 |
Liver Cirrhosis, Biliary/immunology | 2 | 13.0 |
In Vitro | 2 | 0.0 |
Linkage (Genetics) | 2 | 0.0 |
*Mutation | 3 | 0.0 |
Pelger-Huet Anomaly/*genetics/pathology | 2 | 100.0 |